Post by Boehringer Ingelheim

#PRESS: The UAE is now the first country in the India, Middle East, Turkey and Africa (IMETA) region to approve a new therapy for idiopathic and other forms of progressive pulmonary fibrosis. This brings innovative treatment to patients without delay and gives people living with these conditions a new option to help slow disease progression. Read more about the approval: http://bit.ly/4vLb5HU